American Society of Hirudotherapy

Jordan Food and Drug Administration

JFDA · Jordan · middle east

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Jordan's Food and Drug Administration — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national pharmaceutical and medical device framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
middle east
Country
Jordan
Leech status
unregulated
Last ASH review
2026-05-26

Relevant Regulation Codes

  • Jordanian Food and Drug Administration Law
  • Jordanian national medical device regulatory framework

Prescriber Requirements

  • Jordan Medical Council–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

JFDA registration as applicable; Arabic and English-language labelling. Standard cold-chain conditions.

Import/Export Rules

JFDA import authorisation; Ministry of Agriculture veterinary clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Not covered under public insurance schemes for leech therapy specifically.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. JFDA functions as a consolidated authority for both medicines and medical devices; specific live-organism device guidance has not been independently mapped by ASH.

Related Jurisdictions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.